05.10.2021 15:39:24

Moderna: EMA Authorizes Third Dose Of COVID-19 Vaccine For Immunocompromised Individuals

(RTTNews) - Moderna, Inc., (MRNA) announced the European Medicines Agency has authorized a third dose of the COVID-19 vaccine (Spikevax) given at least 28 days after the second dose to severely immunocompromised individuals 12 years of age or older. The company said a growing number of studies have shown the benefit of a third dose in immunocompromised subjects.

Spikevax was formerly known as COVID-19 Vaccine Moderna. It is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike protein.

Analysen zu Moderna Incmehr Analysen

19.11.24 Moderna Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
13.09.24 Moderna Underweight JP Morgan Chase & Co.
05.08.24 Moderna Sector Perform RBC Capital Markets
12.01.24 Moderna Outperform RBC Capital Markets
03.11.23 Moderna Buy Goldman Sachs Group Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Moderna Inc 39,29 -0,91% Moderna Inc